The antifibrotic effect of TGF-β1 siRNAs in murine model of liver cirrhosis

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1072-1078

  Kim, Kyung Hyun ^a   Kim, Hyun Chul ^b   Hwang, Mee Yul ^a   Oh, Hoon Kyu ^a   Lee, Tae Sung ^a   Chang, Young Chae ^a   Song, Ho Jung ^a   Won, Nam Hee ^c   Park, Kwan Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Liver cirrhosis; RNA interference; siRNA; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; FIBROGENESIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CARBON TETRACHLORIDE POISONING; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MURINAE;

EID: 33646488392     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.087     Document Type: Article

References (20)

1. Friedman S.L. Liver fibrosis-from bench to bedside. J. Hepatol. 38 Suppl 1 (2003) S38-S53
2. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci. 7 (2002) d793-d807
3. Bissell D.M. Chronic liver injury, TGF-β, and cancer. Exp. Mol. Med. 33 (2001) 179-190
4. Aboul-Fadl T. Antisense oligonucleotides: the state of the art. Curr. Med. Chem. 12 (2005) 2193-2214
5. Sioud M., and Iversen P.O. Ribozymes, DNAzymes, and small interfering RNAs as therapeutics. Curr. Drug Targets 6 (2005) 647-653
6. Arias M., Sauer-Lehnen S., Treptau J., Janoschek N., Theuerkauf I., Buettner R., Gressner A.M., and Weiskirchen R. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 3 (2003) 29
7. Bernstein E., Caudy A.A., Hammond S.M., and Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 363-366
8. Dykxhoorn D.M., and Lieberman J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 56 (2005) 401-423
9. Miyagishi M., and Taira K. U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497-500
10. Reich S.J., Fosnot J., Kuroki A., Tang W., Yang X., Maguire A.M., Bennett J., and Tolentino M.J. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 9 (2003) 210-216
11. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., and Lee P.J. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279 (2004) 10677-10684
12. Dorn G G., Patel S., Wotherspoon G., Hemmings-Mieszczak M., Barclay J., Natt F.J., Martin P., Bevan S., Fox A., Ganju P., Wishart W., and Hall J. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32 (2004) e49
13. Takabatake Y., Isaka Y., Mizui M., Kawachi H., Shimizu F., Ito T., Hori M., and Imai E. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther. 12 (2005) 965-973
14. Achenbach T.V., Brunner B., and Heermeier K. Oligonucleotide-based knockdown technologies: antisense versus RNA interference. Chembiochem 4 (2003) 928-935
15. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Role of TGF-β in hepatic fibrosis. Front Biosci. 7 (2002) 793-807
16. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
17. Tuschl T. Expanding small RNA interference. Nat. Biotechnol. 20 (2002) 446-448
18. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
19. Desmouliere A., Tuchweber B., and Gabbiani G. Role of the myofibroblast differentiation during liver fibrosis. J. Hepatol. 22 (1995) 61-64
20. Yeh T.S., Ho Y.P., Huang S.F., Yeh J.N., Jan Y.Y., and Chen M.F. Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats. J. Hepatol. 41 (2004) 606-612